Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous CAR T cells U87

A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for an as of yet undisclosed tumor-associated antigen (TAA), with potential immunostimulating and antineoplastic activities. Upon administration, autologous CAR T cells U87 specifically targets and binds to tumor cells that express the undisclosed TAA, resulting in tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous CAR T lymphocytes U87
Code name:U 87
U-87
U87
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search